Effect of Marihuana on Intraocular and Blood Pressure in Glaucoma

      This paper is only available as a PDF. To read, Please Download here.


      Marihuana inhalation was accompanied by increased heart rate and decreased intraocular and blood pressure in 18 subjects with heterogenous glaucomas. The hypotensive effects appeared in 60 to 90 minutes as the decrease in intraocular pressure (IOP) appeared to follow the decrease in blood pressure. In addition to any local effect, the mechanism of lowered IOP may also involve the decreased pressure perfusing the ciliary body vasculature as a result of the peripheral vasodilatory properties of marihuana. Postural hypotension, tachycardia, palpitations, and alterations in mental status occurred with such frequency as to mitigate against the routine used in the general glaucoma population. Our data indicate that further research should be directed to local means of delivering the ocular hypotensive cannabino to the glaucomatous eye.

      Key words

      To read this article in full you will need to make a payment


      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hepler RS
        • Frank IR
        Marihuana smoking and intraocular pressure.
        JAMA. 1971; 217: 1392
        • Lockhart AB
        • West ME
        • Lowe HIC
        The potential use of Cannabis sativa in ophthalmology.
        West Indies Med J. 1977; 26: 66-70
        • Merritt JC
        • Reid LA
        • Smith R
        • Harris DF
        Diurnal intraocular pressure in juvenile open angle glaucoma.
        Ann Ophthalmol. 1979; 11: 253-260
        • Crawford WJ
        • Merritt JC
        Effect of tetrahydrocannabinol on arterial and intraocular hypertension.
        Int J Clin Pharm Biopharm. 1979; 17: 191-196
        • Crawford WJ
        • Alexander PC
        • Me rritt JC
        • Thombs MJ
        Tetrahydrocannabinol effects on elevated blood pressure in humans.
        Prev Med. 1978; 7: 54
        • Green K
        • Wynn H
        • Bowman KA
        A comparison of topical cannabinoids on intraocular pressure.
        Exp Eye Res. 1978; 27: 239-246
        • Green K
        • Kim K
        Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system.
        Exp Eye Res. 1976; 23: 443-448
        • Green K
        • Bigger JF
        • Kim K
        • Bowman K
        Cannabinoid action on the eye as mediated through the central nervous system and local adrenergic activity.
        Exp Eye Res. 1977; 24: 189-196
        • Green K
        • Kim K
        Interaction of adrenergic antagonist with prostaglandin E2 and tetrahydrocannabinol in the eye.
        Invest Ophthalmol. 1976; 15: 102-112
        • Levy NS
        • Rawitscher R
        The effect of systemic hypotension during cardiopulmonary bypass on the intraocular pressure and visual function in humans.
        Ann Ophthalmol. 1977; 9: 1547-1552
        • Bulpitt CJ
        • Hodes C
        • Everett MG
        Intraocular pressure and systemic blood pressure in the elderly.
        Br J Ophthalmol. 1975; 59: 717-720
        • Crawford WJ
        • Cothran LN
        • Daniels ML
        • Tearney RJ
        Direct association of systemic and intraocular hypertension.
        Prev Med. 1979; 8: 146
        • Beaconsfield P
        • Ginsburg J
        • Rainsburg R
        Marihuana smoking—cardiovascular effects in man and possible mechanisms.
        N Eng J Med. 1972; 287: 209-212
        • Martz R
        • Brown DJ
        • Forney RB
        • Bright TP
        • Kiplinger GF
        • Rodda BE
        Propranolol antagonism of marihuana induced tachycardia.
        Life Sci. 1972; 11: 999-1005
        • Kanakis C
        • Pouget JM
        • Rosen KM
        The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
        Circulation. 1976; 53: 703-707
        • Perez-Reyes M
        • Lipton MA
        • Timmons MC
        • Wall ME
        • Brine DR
        • Davis KH
        Pharmacology of orally administered A 9 tetrahydrocannabinol.
        Clin Pharm Ther. 1973; 14: 48-55
        • Benowitz NL
        • Rosenberg J
        • Rogers W
        • Bachman J
        • Jones RT
        Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms.
        Clin Pharm Ther. 1979; 25: 440-446
        • Vachon L
        • Mikus P
        • Morrissey W
        • FitzGerald M
        • Gaensler E
        Bronchial effect of marihuana smoke in asthma.
        in: The Pharmacology of Marihuana. Raven Press, New York1976: 777-784